Ictericia neonatal asociada al uso de oxitocina durante el trabajo de parto. Hospital de Especialidades José Carrasco Arteaga. Periodo enero del 2018 a enero del 2019

Abstract

Background: The use of oxytocin is very frequent at hospital level, its use being relatively high for the stimulation of birth labor when it’s prolonged, causing neonatal jaundice as a consequence and frequent pathology. Objective: To establish the existence of a correlation between the use of oxytocin, during the labor birth, and the development of neonatal jaundice in newborns at the José Carrasco Arteaga Specialty Hospital from January 2018 to January 2019. Material and methods: It’s a cross-sectional and analytical study of the clinical records of term neonates, of mothers with no medical or obstetric history in whom oxytocin was used during birth, without complications during or after birth and who presented jaundice. Data collection was carried out using a form (Annex 1), with results obtained in numerical and percentage tables, with a confidence interval of 95%, a p value less than 0.05 and Odds Ratio to show significant relation. Results: From a sample of 408 term infants, 49 were diagnosed with jaundice and only 13 of them used oxytocin. Conclusions: The prevalence of neonatal jaundice is 26.5%, OR of 0.572 with a 95% CI (0.293-1.116) and a p-value of 0.98, indicating that its use does not correlate with the pathology. Jaundice on average occurs at week 39 of gestation, in females weighing between 2500 and 2999; of which 8 received phototherapy and 1 exchange transfusion.